ATIC - de Cabo,C.; Prieto-Martin,A.; Laffont-Proust,I.; Hässig,R.; Aceves Luquero,C.I.; Sanchez-Prieto,R.; Munoz de la Pascua,L.; Lopez,D.E.; Volland,H.; Moya,K.L. - Brain PrPc is increased during audiogenic seizures. - International Conference - Prion 2005: Between fundamentals and society's needs - 19.10.-21.10.2005, Congress Center Düsseldorf - Poster Session: Cell Biology of PrPc and PrPsc CELL-34
ATNN - Feraudet,C.; Lacroux,C.; Morel,N.; Simon,S.; Volland,H.; Frobert,Y.; Creminon,C.; Andreoletti,O.; Grassi,J. - In vivo immunotherapeutic effect of anti-PrP monoclonal antibodies on mouse models of TSE infection: pharmacodynamic and pharmacokinetic analysis. - International Conference - Prion 2005: Between fundamentals and society's needs - 19.10.-21.10.2005, Congress Center Düsseldorf - Poster Session: Human prions, risk of blood products, and therapy HUMAN-11
ARPD - Feraudet,C.; Morel,N.; Simon,S.; Volland,H.; Frobert,Y.; Creminon,C.; Vilette,D.; Lehmann,S.; Grassi,J. - Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPsc replication in infected cells - The Journal of Biological Chemistry 2005 Mar 25; 280(12): 11247-58
AOSL - Feraudet,C.; Morel,N.; Simon,S.; Volland,H.; Frobert,Y.; Vilette,D.; Lehmann,S.; Creminon,C.; Grassi,J. - Screening of 141 monoclonal antibodies for their capacity to inhibit PrPsc replication in infected cells - International Conference - Prion diseases: from basic research to intervention concepts - TSE-Forum, 08.10.-10.10.2003, Gasteig, München - Oral sessions OS-36
ATGQ - Grassi,J.; Morel,N.; Simon,S.; Feraudet,C.; Boutal,H.; Volland,H.; Frobert,Y.; Creminon,C. - The use of anti-PrP antibodies for the diagnosis and therapy of prion diseases - International Conference - Prion 2005: Between fundamentals and society's needs - 19.10.-21.10.2005, Congress Center Düsseldorf - Oral sessions ORAL-47
AQMY - Morel,N.; Simon,S.; Frobert,Y.; Volland,H.; Mourton-Gilles,C.; Negro,A.; Sorgato,M.C.; Creminon,C.; Grassi,J. - Selective and efficient immunoprecipitation of the disease-associated form of the prion protein can be mediated by nonspecific interactions between monoclonal antibodies and scrapie-associated fibrils - The Journal of Biological Chemistry 2004 Jul 16; 279(29): 30143-9
AOWZ - Morel,N.; Simon,S.; Frobert,Y.; Volland,H.; Creminon,C.; Grassi,J. - Specific determination of PrPsc by a combined use of plasminogen and monoclonal antibodies. Application to the diagnosis of prion diseases. - International Conference - Prion diseases: from basic research to intervention concepts - TSE-Forum, 08.10.-10.10.2003, Gasteig, München - Poster session - DG-28
ASKP - Moya,K.L.; Hässig,R.; Breen,K.C.; Volland,H.; Di Giamberardino,L. - Axonal transport of the cellular prion protein is increased during axon regeneration - Journal of Neurochemistry 2005 Mar; 92(5): 1044-53
AOXU - Peoc'h,K.; Frobert,Y.; Volland,H.; Boquet,D.; Sato,T.A.; Clement,G.; Grassi,J.; Laplanche,J.L.; Creminon,C. - Production of monoclonal antibodies against 14-3-3 protein and their use for CJD diagnosis - International Conference - Prion diseases: from basic research to intervention concepts - TSE-Forum, 08.10.-10.10.2003, Gasteig, München - Poster session - DG-40
ANKY - Peoc'h,K.; Volland,H.; de Gassart,A.; Beaudry,P.; Sazdovitch,V.; Sorgato,M.C.; Creminon,C.; Laplanche,J.L.; Lehmann,S. - Prion-like protein Doppel expression is not modified in scrapie-infected cells and in the brains of patients with Creutzfeldt-Jakob disease - FEBS Letters 2003 Feb 11; 536(1-3): 61-5